as short chain hydroperoxides) using GSH as an electron donor and for hydrolysis of phospholipids; i.e., it exhibits both GSH peroxidase (GPx) and phospholipase A 2 (PLA 2 ) activities ( 1 ). These activities require the binding of Prdx6 to phospholipids in a specifi c orientation in relation to cys47, the active site for GPx activity, and to S32-H26-D140, the catalytic triad for PLA 2 activity ( 2, 3 ). The GPx activity of Prdx6 plays a key role in the antioxidant defense of the lung, as well as other organs ( 4-8 ), and has been shown recently to participate in the repair of peroxidized cell membranes by reduction of phospholipid hydroperoxides ( 3, 9 ). The PLA 2 activity of Prdx6 also participates in the repair of peroxidized cell membranes by liberating the sn -2 oxidized fatty acid to generate lysophosphatidylcholine (LPC) ( 9, 10 ). Additionally, the PLA 2 activity participates in the turnover of lung surfactant phospholipids with a major function in phospholipid remodeling to generate the dipalmitoylphosphatidylcholine (DPPC) that is the surface-active lipid component of the lung surfactant (11)(12)(13)(14)(15). Both the repair of peroxidized cell membrane phospholipids and a pathway for DPPC synthesis require the combined activity of PLA 2 followed by a LPC acyl transferase (LPCAT) activity in order to either regenerate a reduced membrane phospholipid or to remodel phosphatidylcholine (PC) to produce DPPC . This pathway that combines PLA 2 activity followed by LPCAT activity has been designated as the remodeling pathway for PC synthesis (Lands cycle) ( 16 ).These metabolic functions of PLA 2 that are associated with phospholipid turnover and membrane repair are clearly compartmentalized within cells. While DPPC synthesis via the de novo (Kennedy) pathway occurs in the Peroxiredoxin (Prdx)6 is a 1-cys member of the Prdx family that has the unique combination of activities for both reduction of phospholipid hydroperoxides (as well